Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
ACSS Consortium welcomes the U.K. as its newest member - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 211682
Later capture
ACSS Consortium welcomes the U.K. as its newest member - Canada.ca
Jan 2, 2026
hc-20260101
ID 428918
updated1 sections changed
1 sections changed0 added0 removed+0 / -1 linesChange ratio: 4%
--- +++ @@ -8,5 +8,4 @@ Access will update the guidance for industry on how to apply to have products considered for marketing authorization in the 5 member countries, including the U.K. This guidance will be available on January 1, 2021. The MHRA is delighted to be joining, as this is a significant step for U.K. medicines regulation and for patient health. With the addition of the U.K., Access will increase international cooperation and bring more timely access to medicines to an even larger population. Page details-Date modified: 2022-10-11